Mitochondrial DNA sequence heterogeneity of single CD34+ cells after nonmyeloablative allogeneic stem cell transplantation

Stem Cells

Volumn 25, Issue 10, 2007, Pages 2670-2676

  Yao, Yong Gang ^a,b   Childs, Richard W ^a   Kajigaya, Sachiko ^a   McCoy Jr , J Philip ^b   Young, Neal S ^a  

^a Hematology Branch   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

CD34+ cell; Kinetics; Mitochondrial DNA; Nonmyeloablative allogeneic stem cell transplantation; Single cell analysis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; LEUKOCYTE ANTIGEN; MITOCHONDRIAL DNA;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CD34 SELECTION; CELL CLONING; CELL HETEROGENEITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG BLOOD LEVEL; FEMALE; GENE MUTATION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; MALE;

ADULT; AGED; ANTIGENS, CD34; CELL LINEAGE; CELL SEPARATION; CLONE CELLS; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SIBLINGS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 35348879649     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0269     Document Type: Article

References (52)

1. Dick JE, Magli MC, Huszar D et al. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell 1985;42:71-79.
2. Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 1986;45:917-927.
3. Dick JE, Lapidot T. Biology of normal and acute myeloid leukemia stem cells. Int J Hematol 2005;82:389-396.
4. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106:1901-1910.
5. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 2004;103:1580-1585.
6. Camargo FD, Chambers SM, Drew E et al. Hematopoietic stem cells do not engraft with absolute efficiencies. Blood 2006;107:501-507.
7. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-377.
8. Osawa M, Hanada K, Hamada H et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242-245.
9. Spangrude GJ, Brooks DM, Tumas DB. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function. Blood 1995;85:1006-1016.
10. Abkowitz JL, Catlin SN, McCallie MT et al. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood 2002;100:2665-2667.
11. Gordon MY, Lewis JL, Marley SB. Of mice and men . . . and elephants. Blood 2002;100:4679-4680.
12. Shepherd BE, Guttorp P, Lansdorp PM et al. Estimating human hematopoietic stem cell kinetics using granulocyte telomere lengths. Exp Hematol 2004;32:1040-1050.
13. Abkowitz JL, Persik MT, Shelton GH et al. Behavior of hematopoietic stem cells in a large animal. Proc Natl Acad Sci U S A 1995;92:2031-2035.
14. Prchal JT, Prchal JF, Belickova M et al. Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism. J Exp Med 1996;183:561-567.
15. Morris E, Thomson K, Craddock C et al. Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood 2004;104:3865-3871.
16. Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000;343:750-758.
17. Childs R, Clave E, Contentin N et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses. Blood 1999;94:3234-3241.
18. Peggs KS, Hunter A, Chopra R et al. Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet 2005;365:1934-1941.
19. Giralt S, Thall PF, Khouri I et al. Melphalan and purine analog-containing preparative regimens: Reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001;97:631-637.
20. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998;91:756-763.
21. Deeg HJ, Maris MB, Scott BL et al. Optimization of allogeneic transplant conditioning: Not the time for dogma. Leukemia 2006;20:1701-1705.
22. Baron F, Sandmaier BM. Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. Leukemia 2006;20:1690-1700.
23. Griffith LM, McCoy JP Jr, Bolan CD et al. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 2005;128:668-675.
24. + dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors. Blood 2004;103:1560-1563.
25. Mackinnon S, Barnett L, Bourhis JH et al. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: Evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood 1992;80:3235-3241.
26. Mackinnon S, Barnett L, Heller G et al. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 1994;83:3409-3416.
27. Shin MG, Kajigaya S, Tarnowka M et al. Mitochondrial DNA sequence heterogeneity in circulating normal human CD34 cells and granulocytes. Blood 2004;103:4466-4477.
28. Ogasawara Y, Nakayama K, Tarnowka M et al. Mitochondrial DNA spectra of single human CD34+ cells, T cells, B cells, and granulocytes Blood 2005;106:3271-3284.
29. Yao Y-G, Ellison FM, McCoy JP et al. Age-dependent accumulation of mtDNA mutations in murine hematopoietic stem cells is modulated by the nuclear genetic background. Hum Mol Genet 2007;16:286-294.
30. Yao Y-G, Ogasawara Y, Kajigaya S et al. Mitochondrial DNA sequence variation in single cells from leukemia patients. Blood 2007;109:756-762.
31. Shin MG, Kajigaya S, McCoy JP Jr et al. Marked mitochondrial DNA sequence heterogeneity in single CD34+ cell clones from normal adult bone marrow. Blood 2004;103:553-561.
32. Childs RW, Clave E, Tisdale J et al. Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: Evidence for a graft-versus-tumor effect. J Clin Oncol 1999;17:2044-2049.
33. Andrews RM, Kubacka I, Chinnery PF et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 1999;23:147.
34. Bandelt H-J, Forster P, Röhl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 1999;16:37-48.
35. Macaulay V, Hill C, Achilli A et al. Single, rapid coastal settlement of Asia revealed by analysis of complete mitochondrial genomes. Science 2005;308:1034-1036.
36. Yao Y-G, Kong Q-P, Bandelt H-J et al. Phylogeographic differentiation of mitochondrial DNA in Han Chinese. Am J Hum Genet 2002;70:635-651.
37. Salas A, Bandelt H-J, Macaulay V et al. Phylogeographic investigations: The role of trees in forensic genetics. Forensic Sci Int 2007;168:1-13.
38. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu Rev Genet 2005;39:359-407.
39. Chinnery PF, Samuels DC, Elson J et al. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: Is there a common mechanism? Lancet 2002;360:1323-1325.
40. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005;6:389-402.
41. Chomyn A, Attardi G. MtDNA mutations in aging and apoptosis. Biochem Biophys Res Commun 2003;304:519-529.
42. Blazar BR, Orr HT, Arthur DC et al. Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood 1985;66:1436-1444.
43. Durnam DM, Anders KR, Fisher L et al. Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 1989;74:2220-2226.
44. Suttorp M, Schmitz N, Dreger P et al. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms. Leukemia 1993;7:679-687.
45. Price CM, Colman SM, Kanfer EJ. Persistence of multilineage host haemopoiesis following allogeneic bone marrow transplantation. Br J Haematol 1995;90:465-468.
46. Andreani M, Manna M, Lucarelli G et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood 1996;87:3494-3499.
47. Alizadeh M, Bernard M, Danic B et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002;99:4618-4625.
48. Hochberg EP, Miklos DB, Neuberg D et al. A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood 2003;101:363-369.
49. Fredriksson M, Barbany G, Liljedahl U et al. Assessing hematopoietic chimerism after allogeneic stem cell transplantation by multiplexed SNP genotyping using microarrays and quantitative analysis of SNP alleles. Leukemia 2004;18:255-266.
50. Wang JC, Dick JE. Cancer stem cells: Lessons from leukemia. Trends Cell Biol 2005;15:494-501.
51. Clave E, Rocha V, Talvensaari K et al. Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood 2005;105:2608-2613.
52. Singer JW, Keating A, Ramberg R et al. Long-term stable hematopoietic chimerism following marrow transplantation for acute lymphoblastic leukemia: A case report with in vitro marrow culture studies. Blood 1983;62:869-872.